Momina Krepost AD (XBUL:MKR) EBIT: €-0.64 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:MKR Momina Krepost AD XBUL:MKR
9 GF Score
Price €0.50
GF Value €1.83
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Momina Krepost AD EBIT?

Momina Krepost AD XBUL:MKR 9 EBIT is €-0.64 Mil as of Jun. 2026. GuruFocus rates XBUL:MKR with a GF Score™ of 9/100 and a GF Value™ of €1.83 (Possible Value Trap). The stock has 6 warning signs investors should review.

Momina Krepost AD's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was €-0.16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was €-0.64 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Momina Krepost AD's annualized ROC % for the quarter that ended in Jun. 2026 was -9.69%. Momina Krepost AD's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -12.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Momina Krepost AD's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -36.98%.


Momina Krepost AD  (XBUL:MKR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Momina Krepost AD's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=-0.724 * ( 1 - 0% )/( (7.425 + 7.513)/ 2 )
=-0.724/7.469
=-9.69 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Momina Krepost AD's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.624/( ( (4.921 + max(-2.693, 0)) + (4.884 + max(-2.863, 0)) )/ 2 )
=-0.624/( ( 4.921 + 4.884 )/ 2 )
=-0.624/4.9025
=-12.73 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.644 + 1.583 + 0.101) - (2.545 + 0 + 2.476)
=-2.693

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.636 + 1.586 + 0.074) - (2.555 + 0 + 2.604)
=-2.863

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Momina Krepost AD's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=-0.635/1.717
=-36.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Momina Krepost AD EBIT Related Terms


Momina Krepost AD EBIT Historical Data

* Premium members only.

The historical data trend for Momina Krepost AD's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Momina Krepost AD EBIT Chart

Momina Krepost AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 -0.21 -0.52 -0.76 -0.74

Momina Krepost AD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.14 -0.21 -0.13 -0.16

XBUL:MKR vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Momina Krepost AD's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Momina Krepost AD EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Momina Krepost AD's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Momina Krepost AD's EV-to-EBIT falls into.


XBUL:MKR
9GF Score
Momina Krepost AD XBUL:MKR
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Momina Krepost AD EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-0.64 Mil mean?
Momina Krepost AD (XBUL:MKR) has a EBIT of €-0.64 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Momina Krepost AD.
Is Momina Krepost AD's EBIT too high?
Momina Krepost AD's current EBIT is €-0.64 Mil. Overall, Momina Krepost AD has a GF Score™ of 9/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Momina Krepost AD's EBIT compare to ISRG and BDX?
Momina Krepost AD's EBIT of €-0.64 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Momina Krepost AD. Momina Krepost AD's current EBIT is €-0.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Momina Krepost AD stock overvalued right now?
Based on GuruFocus' analysis, Momina Krepost AD (XBUL:MKR) is currently considered Possible Value Trap. The stock's GF Value™ is €1.83, compared to a current price of €0.50 — trading 72.7% below its estimated fair value. The current EBIT is €-0.64 Mil. Momina Krepost AD's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Momina Krepost AD (XBUL:MKR), the current EBIT is €-0.64 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Momina Krepost AD (XBUL:MKR) Overvalued in 2026?

Based on GuruFocus' analysis, Momina Krepost AD stock appears to be undervalued. The current stock price of €0.50 is trading 72.7% below its estimated GF Value™ of €1.83. GuruFocus considers Momina Krepost AD to be Possible Value Trap.

Key valuation signals for XBUL:MKR:

  • EBIT: €-0.64 Mil
  • GF Value™: €1.83 vs. price of €0.50 (72.7% below fair value)
  • GF Score™: 9/100 with 6 warning signs

No single metric tells the full story. See the XBUL:MKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Momina Krepost AD Business Description

Address 23, Magistralna Street, Veliko Tarnovo, BGR, 5000
Momina Krepost AD is engaged in the production and sales of medical products. The product portfolio includes syringes, injection needles, tubes, catheter, medical clothes, urine collecting bags, among others.
9GF Score

Get the complete analysis for XBUL:MKR

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price
€1.83
GF Value